Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (7)
- Bioenergy (1)
- Computer Science (1)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (6)
- Isotopes (3)
- Materials Science (1)
- Molten Salt (1)
- Neutron Science (3)
- Nuclear Energy (18)
- Physics (1)
- Space Exploration (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.